Health
Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults – Medical Xpress
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune re…
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of Medicine describes the findings from the study, which was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19 disease.
The experimental vaccine,…
-
Noosa News23 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General22 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
Noosa News20 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points